(Q46387477)

21 December 2017

title

AT1-receptor antagonism reverses the blood pressure elevation associated with diet-induced obesity (English)

1 reference

21 December 2017

0 references

Carine M Boustany

1

1 reference

21 December 2017

David R Brown

series ordinal

2

1 reference

21 December 2017

David C Randall

series ordinal

3

1 reference

21 December 2017

Lisa A Cassis

series ordinal

4

1 reference

21 December 2017

publication date

17 March 2005

1 reference

21 December 2017

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

published in

1 reference

21 December 2017

volume

289

1 reference

21 December 2017

issue

1

1 reference

21 December 2017

page(s)

R181-6

1 reference

21 December 2017

The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00507.2004

Control of differentiation-induced calbindin-D9k gene expression in Caco-2 cells by cdx-2 and HNF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00507.2004

Hemodynamic alterations in hypertensive obese rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00507.2004

Angiotensinogen levels and obesity in four black populations. ICSHIB Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00507.2004

ACE, angiotensinogen and obesity: a potential pathway leading to hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00507.2004

Obesity, hypertension, and sympathetic nervous system activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00507.2004

The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00507.2004

Obesity and hypertension: two epidemics or one?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00507.2004

Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00507.2004

Development of hypertension in a rat model of diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00507.2004

Oxidative stress in a rat model of obesity-induced hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00507.2004

The kidney, hypertension, and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00507.2004

Role of sympathetic nervous system and neuropeptides in obesity hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00507.2004

Is obesity a major cause of chronic kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00507.2004

Obesity-associated hypertension and kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00507.2004

Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00507.2004

Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00507.2004

Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00507.2004

Effect of Weight Loss without Salt Restriction on the Reduction of Blood Pressure in Overweight Hypertensive Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00507.2004

Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00507.2004

The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00507.2004

Plasma angiotensinogen concentrations in obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00507.2004

Increased adipose angiotensinogen gene expression in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00507.2004

10.1152/AJPREGU.00507.2004

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017